China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
09/30/2025
06/30/2025
03/31/2025
12/31/2024
Revenue
4
1
0
1
1
1
Revenue Growth (YoY)
0%
0%
-100%
--
0%
-50%
Cost of Revenue
4
1
0
1
1
1
Gross Profit
0
0
0
0
0
0
Selling, General & Admin
1
0
0
0
0
0
Research & Development
0
0
0
0
0
0
Operating Expenses
3
1
0
0
0
1
Other Non Operating Income (Expenses)
0
0
0
0
--
--
Pretax Income
-3
-1
0
0
0
-1
Income Tax Expense
0
0
0
0
0
0
Net Income
-3
-1
0
0
0
-1
Net Income Growth
-25%
0%
-100%
-100%
--
0%
Shares Outstanding (Diluted)
6.76
6.76
3.87
3.26
3.26
2.3
Shares Change (YoY)
193%
193%
124%
102%
148%
217%
EPS (Diluted)
-0.47
-0.18
-0.16
-0.16
-0.24
-0.53
EPS Growth
-77%
-66%
-74%
-82%
-67%
-69%
Free Cash Flow
0
0
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
0%
0%
Operating Margin
-75%
-100%
0%
0%
0%
-100%
Profit Margin
-75%
-100%
0%
0%
0%
-100%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
-3
-1
0
0
0
-1
EBITDA Margin
-75%
-100%
0%
0%
0%
-100%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-3
-1
0
0
0
-1
EBIT Margin
-75%
-100%
0%
0%
0%
-100%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are China Pharma Holdings Inc's key financial statements?
According to the latest financial statement (Form-10K), China Pharma Holdings Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for CPHI?
China Pharma Holdings Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is China Pharma Holdings Inc's revenue broken down by segment or geography?
China Pharma Holdings Inc largest revenue segment is Pharmaceutical Products, at a revenue of 4,144,268 in the most earnings release.For geography, China is the primary market for China Pharma Holdings Inc, at a revenue of 4,144,268.
Is China Pharma Holdings Inc profitable?
no, according to the latest financial statements, China Pharma Holdings Inc has a net loss of $0
Does China Pharma Holdings Inc have any liabilities?
no, China Pharma Holdings Inc has liability of 0
How many outstanding shares for China Pharma Holdings Inc?
China Pharma Holdings Inc has a total outstanding shares of 0